Kimoto S, Bazmi HH, Lewis DA. Lower expression of glutamic acid decarboxylase 67 in the prefrontal cortex in schizophrenia: contribution of altered regulation by Zif268. Am J Psychiatry. 2014;171(9):969-78. DOI: 10.1176/appi.ajp.2014.14010004. PubMed PMID: 24874453.
Dubovsky SL, Daurignac E, Leonard KE. Increased platelet intracellular calcium ion concentration is specific to bipolar disorder. J Affect Disord. 2014;164:38-42. DOI: 10.1016/j.jad.2014.04.025. PubMed PMID: 24856551.
Sara GE, Burgess PM, Malhi GS, Whiteford HA, Hall WC. The impact of cannabis and stimulant disorders on diagnostic stability in psychosis. J Clin Psychiatry. 2014;75(4):349-56. DOI: 10.4088/JCP.13m08878. PubMed PMID: 24813404.
Rabinowitz J, Werbeloff N, Caers I, Mandel FS, Stauffer V, Ménard F, et al.. Determinants of antipsychotic response in schizophrenia: implications for practice and future clinical trials. J Clin Psychiatry. 2014;75(4):e308-16. DOI: 10.4088/JCP.13m08853. PubMed PMID: 24813414.
Levine SZ, Leucht S. Treatment response heterogeneity in the predominant negative symptoms of schizophrenia: analysis of amisulpride vs placebo in three clinical trials. Schizophr Res. 2014;156(1):107-14. DOI: 10.1016/j.schres.2014.04.005. PubMed PMID: 24794879.